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Acute infection of cattle with bovine herpesvirus 1 (BHV-1) represses cell-mediated immunity, which can
lead to secondary bacterial infections. Since BHV-1 can induce apoptosis of cultured lymphocytes, we hypoth-
esized that these virus-host interactions occur in cattle. To test this hypothesis, we analyzed lymph nodes and
peripheral blood mononuclear cells (PBMC) after calves were infected with BHV-1. In situ terminal de-
oxynucleotidyltransferase-mediated dUTP nick end-labeling (TUNEL) staining of lymphoid tissues (pharyn-
geal tonsil, cervical, retropharyngeal, and inguinal) was used to detect apoptotic cells. Calves infected with
BHV-1 for 7 days revealed increased apoptotic cells near the corticomedullary junction in lymphoid follicles
and in the subcapsular region. Increased frequency of apoptotic cells was also observed in the mucosa-
associated lymphoid tissue lining the trachea and turbinate. Immunohistochemistry of consecutive sections
from pharyngeal tonsil revealed that CD21 T lymphocytes were positive for the BHV-1 envelope glycoprotein
gD. The location of these CD21 T lymphocytes in the germinal center suggested that they were CD41 T cells.
Electron microscopy and TUNEL also revealed apoptotic and herpesvirus-infected lymphocytes from this area.
Fluorescence-activated cell sorting analyses demonstrated that CD41 and CD81 T cells decreased in lymph
nodes and PBMC after infection. The decrease in CD41 T cells correlated with an increase in apoptosis. CD41
but not CD81 lymphocytes were infected by BHV-1 as judged by in situ hybridization and PCR, respectively.
Immediate-early (bovine ICP0) and early (ribonucleotide reductase) transcripts were detected in PBMC and
CD41 lymphocytes prepared from infected calves. In contrast, a late transcript (glycoprotein C) was not
consistently detected suggesting productive infection was not efficient. Taken together, these results indicate
that BHV-1 can infect CD41 T cells in cattle, leading to apoptosis and suppression of cell-mediated immunity.
Bovine herpesvirus 1 (BHV-1) is an important viral patho-
gen of cattle that can cause severe respiratory infection, con-
junctivitis, abortion, vulvovaginitis, balanopostitis, and sys-
temic infection in neonate calves. Secondary bacterial
infections resulting in pneumonia and death are common (re-
viewed in reference 58). BHV-1 belongs to the Alphaherpes-
virinae subfamily and shares a number of biological properties
with herpes simplex virus types 1 and 2 (HSV-1 and HSV-2)
(54). BHV-1 establishes lifelong latency in ganglionic neurons
of the peripheral nervous system after initial replication in the
mucosal epithelia (reviewed in reference 27). Virus reactiva-
tion and spread to other susceptible animals occur after natu-
ral or corticosteroid-induced stress.
The mechanism of BHV-1-induced immunosuppression has
been studied following exposure of animals to virulent or vac-
cine virus. Increased susceptibility to secondary infection cor-
relates with depressed cell-mediated immunity after infection.
Infection decreases interleukin-2 (IL-2) receptor expression
(30), impairs IL-2 production, decreases mitogenic stimulation
of peripheral blood mononuclear cells (PBMC) (5), impairs
cytotoxic responses (2), and decreases circulating T lympho-
cytes (14, 15). Inhibition of lymphocyte proliferative responses
may be the result of nonproductive infection (5). Compro-
mised CD81 T-cell recognition of infected cells may, in part,
result from major histocompatibility complex class I repression
by HSV-1 (1, 40, 56, 60) and BHV-1 (12). Down-regulation of
the transporter associated with antigen presentation by BHV-1
also occurred (20). Finally, alphaherpesviruses may induce im-
mune dysfunction by enhancing suppressor T-cell activity (re-
viewed in reference 44).
In humans and mice, the cellular immune response is pre-
dominantly CD41 and Th1-like after HSV-2 infection (37).
CD41 T cells clear virus from cutaneous sites (35) and reduce
establishment of latency because HSV replication at the pri-
mary site of infection is lower (38). CD41 T cells are also the
limiting cell type for antigen-induced proliferation in BHV-1
infection (7). CD4-induced cytotoxicity is directed against in-
fected cells expressing late HSV-1 glycoproteins, whereas
CD8-induced cytotoxicity is directed against immediate-early
(IE) and early (E) proteins (36). CD41 T lymphocytes are
crucial for generating primary cytolytic CD81 T cells against
some HSV-1 antigens (26). CD81 T lymphocytes limit infec-
tion in the peripheral nervous system, maintain the integrity of
neurons during primary HSV infection (53), and resolve HSV
lesions (42). Finally, gamma/delta T cells may be the first line
of defense against HSV infection (34) and protect mice from
HSV-1 induced encephalitis (50).
Apoptosis, or programmed cell death, leads to chromatin
condensation, nuclear fragmentation, and formation of apo-
ptotic bodies. Apoptosis occurs during development and after
virus infection (reviewed in references 19 and 52). Several
viruses have evolved mechanisms that block the host apoptotic
pathway to maximize production of viral progeny and estab-
lishment of latency. HSV-1 antigen-expressing cells and non-
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infected cord blood T lymphocytes stimulated with phytohe-
magglutinin undergo apoptosis (23). HSV-1 infection of
activated T lymphocytes prepared from peripheral blood leads
to apoptosis of CD41 and HLA-DR-positive T lymphocytes
but not CD81 T cells (22). Live and inactivated BHV-1 can
induce apoptosis of cultured PBMC following mitogen stimu-
lation (16–18). Cultured CD41 T lymphocytes that are acti-
vated by standard procedures can be infected resulting in ap-
optosis (9). Apoptosis of T lymphocytes may account for
transient lymphocytopenia and immunosupression following
BHV-1 infection. However, it is not known if lymphocytes are
infected by BHV-1 or if apoptosis occurs following infection of
cattle.
In this study, we demonstrate that reduction of CD41 T
lymphocytes occurs in PBMC and lymph nodes during acute
infection of cattle. Relative to mock-infected calves, higher
levels of apoptosis were detected in lymphoid tissues. BHV-1
DNA, bovine ICP0 (bICP0) RNA (IE), and ribonucleotide
reductase (RR) RNA (E) were consistently detected in CD41
T lymphocytes. These studies demonstrate that BHV-1 infec-
tion of CD41 T lymphocytes leads to apoptosis during acute
infection of cattle. We hypothesize that this novel virus host
interaction plays an important role in virus-induced immuno-
suppression.
MATERIALS AND METHODS
Virus and cells. MDBK cells (American Type Culture Collection, Rockville,
Md.) were maintained in Earle’s modified Eagle’s medium (EMEM) with 10%
fetal calf serum (FCS). The Cooper strain of BHV-1, supplied by the National
Veterinary Services Laboratory, Animal and Plant Health Inspection Services,
Ames, Iowa, was propagated in MDBK cells with a multiplicity of infection of
0.05. When cytopathic effect was evident, virus was harvested, titrated (43) in
MDBK cells, aliquoted, and stored at 270°C.
Animals. Weanling dairy calves (5 to 6 months old) that were not vaccinated
against BHV-1 and were seronegative for BHV-1 were used for these studies.
Calves were inoculated in the right and left conjunctival sacs and intranasally, 1
ml per site, with 107 50% tissue culture infective doses of BHV-1 Cooper strain
per ml. Trachea, turbinate membrane, pharyngeal tonsil, cervical, parotid, ret-
ropharyngeal, and inguinal lymph nodes were obtained at 7 days postinfection
(dpi) from BHV-1-infected or mock-infected calves (7 dpi is the time of the peak
of clinical symptoms and maximal viral gene expression in trigeminal ganglia
[47]). The tissue was fixed in 10% buffered formalin and processed by routine
histological methods. Experiments using animals were done in accordance with
the American Association of Laboratory Animal Care guidelines. Calves were
housed under strict isolation containment and given antibiotics before and after
infection to prevent secondary bacterial infection.
Preparation of CD41 and CD81 lymphocytes from lymphoid organs and
PBMC. Peripheral blood lymphocytes (PBL) and single-cell suspensions from
lymphoid tissue were prepared from mock-infected and BHV-1-infected calves
at 5, 7, 9, 12, and 16 dpi by density gradient centrifugation on Histopaque 1083
(Sigma Chemical Co., St. Louis, Mo.). Cells located at the interface were col-
lected, washed in CMF-PBS (phosphate-buffered saline) (150 mM NaCl, 5 mM
KCl, 100 mM NaHCO3, 14 mM glucose [pH 7.4]), and adjusted to a concentra-
tion of 2 3 107 cells/ml before primary antibody incubation.
To prepare single-cell suspensions from pharyngeal tonsil and retropharyngeal
lymph nodes, tissue fragments were minced with sterilized razor blades in glass
petri dishes. Minced tissue was predigested in 1% trypsin (Gibco) in EMEM
(Sigma) supplemented with 25 mg of gentamicin (Gibco BRL, Grand Island,
N.Y.) per ml for 30 min at 37°C. Trypsin was inactivated by adding 5% FCS, and
samples were centrifuged for 10 min at room temperature (500 3 g). The
supernatant was discarded, and the pellet was suspended in EMEM containing
0.25% of type IV clostridial collagenase (Worthington Biochemical Corp., Free-
hold, N.J.) and digested at 37°C. The mixture was pipetted every 30 min for 2 to
3 h until a single-cell suspension was obtained.
Cells located at the interface after density gradient centrifugation on His-
topaque 1083 were collected, washed in CMF-PBS, and suspended in EMEM
supplemented with 10% FCS. Cell preparations from pharyngeal tonsil and
lymph nodes (but not PBL) were plated on tissue culture dishes for 2 h in at 37°C
in a humidified CO2 incubator to remove adherent cells and debris. Nonadherent
cells were removed by pipetting, and dishes were rinsed with medium. Cells were
then washed in CMF-PBS and adjusted to a concentration of 2 3 107 cells/ml.
Mononuclear cells were incubated with primary monoclonal antibodies, mouse
immunoglobulin G1 (IgG1) anti-bovine CD4 (MCA834; Serotec, Oxford, United
Kingdom) and mouse IgG2a anti-bovine CD8 (MCA837). CD41 and CD81
lymphocytes were purified by positive selection using goat anti-mouse IgG-
coated Dynabeads (M-450; Dynal, Lake Success, N.Y.) according to the manu-
facturers’ recommendation. For fluorescence-activated cell sorting (FACS) anal-
ysis, the same secondary antibodies as described for flow cytometry were used.
Flow cytometry. Indirect immunofluorescence analysis was performed accord-
ing to standard techniques. PBMC were incubated with primary monoclonal
antibodies, mouse IgG1 anti-bovine CD4 and mouse IgG2a anti-bovine CD8, for
1 h at 4°C. Antibodies were diluted according to the manufacturers’ recommen-
dation in CMF-PBS with 1% bovine serum albumin (BSA). PBL were washed for
three times in CMF-PBS at 500 3 g at 4°C for 8 min. Single-color or double-color
immunofluorescence was carried out by incubating with goat anti-mouse IgG1-
phycoerythrin (PE) conjugate (Southern Biotechnology Associates, Inc., Bir-
mingham, Ala.) and/or goat anti-mouse IgG2a-fluorescein isothiocyanate (FITC)
conjugate (Southern Biotechnology Associates) for 1 h at 4°C. PBL were washed
three times and suspended in CMF-PBS. Nonspecific staining was determined by
incubating cells with PE and FITC alone or with isotype-matched control anti-
bodies. Initially, the monoclonal antibody mouse IgG2a anti-bovine CD2 (IL-
A42; gift from S. Srikumaran, Department of Veterinary and Biomedical Sci-
ences, University of Nebraska, Lincoln) was used to determine the gate settings
for lymphocytes. Lymphocyte populations were gated by standard forward and
side scatter properties, which excluded debris and monocytes. Flow cytometry
analysis and cell sorting for CD41 and CD81 lymphocytes were performed with
a FACSVantage (Becton Dickinson Immunocytometry Systems, San Jose, Cal-
if.); 2 3 104 events were acquired and analyzed with the CellQuest program.
The frequency of apoptosis was determined by identifying the number of
propidium iodide (PI)-stained cells containing hypodiploid DNA. CD41 and
CD81 T lymphocytes in PBL were labeled with goat anti-mouse IgG-FITC
secondary antibody (Sigma) and fixed in 70% ethanol for 30 min at 4°C. These
cells were subsequently stained overnight at 4°C in the dark with Telford reagent
(0.01 mM EDTA, 26.8 mg of RNase A per liter [93 U/mg], and 50 mg of PI per
liter, 0.1% Triton X-100 in PBS). The PI fluorescence of individual cells was
measured with a flow cytometer (FACScan; Becton-Dickinson).
Cytospin preparation of CD41 and CD81 lymphocytes. CD41 and CD81
lymphocytes were prepared from mock-infected and BHV-1-infected calves (2, 5,
7, and 9 dpi). These cells were applied to Superfrost Plus slides (Fisher Scientific,
Pittsburgh, Pa.) by centrifugation at 200 3 g for 5 min in a cytocentrifuge at a
density of 5 3 104 per spot. Fixation was performed in 4% paraformaldehyde in
PBS (pH 7.4) for 5 min at room temperature. The slides were then washed in
CMF-PBS and dehydrated with graded ethanol. Dehydrated slides were stored at
4°C. Cells were stained with hematoxylin and eosin for morphological evaluation.
In situ detection of apoptosis. Tissue sections, 4 to 5 mm thick on Superfrost
Plus slides, were deparaffinized in xylene for 10 min, rehydrated in a graded
ethanol series, and treated with proteinase K (20 mg/ml; Gibco BRL) in Tris
buffer (100 mM Tris-HCl, 150 mM NaCl [pH 7.6]) for 20 min at 37°C. Nick end
labeling of DNA strand breaks in the tissue was performed by terminal de-
oxynucleotidyltransferase-mediated dUTP-biotin nick end labeling (TUNEL)
assay, which utilizes alkaline phosphatase (Boehringer Mannheim Corp., India-
napolis, Ind.). Slides were counterstained with methyl green (Vector Laborato-
ries) and then coverslipped with Permount (Fisher).
In situ hybridization (ISH). The DNA probe specific for BHV-1 glycoprotein
C (gC) (229 bp) was contained in plasmid pKS92-2 and was obtained from S. I.
Chowdhury (Kansas State University). The gC fragment was labeled by PCR
with digoxigenin-dUTP (DIG; Boehringer Mannheim). PCR conditions using gC
upstream and downstream primers have been previously described (47). Depro-
teinization of deparaffinized and rehydrated tissue sections of lymphocytes on
slides was carried out in 0.2 N HCl for 20 min at room temperature. Permeabi-
lization with proteinase K (4 mg/ml for cells and 20 mg/ml for tissue; Boehringer
Mannheim) was performed as described for tissue in PBS. After rinsing with PBS
(three times for 5 min each), cells and tissues were fixed in 4% paraformaldehyde
in PBS for 5 min at room temperature. Acetylation was performed to reduce
nonspecific binding of the probe to other reactive groups in 0.1 M triethanol-
amine-HCl buffer (pH 8.0) with 0.25% acetic anhydride. After 5 min of incuba-
tion at room temperature, 0.25% acetic anhydride was added for an additional 5
min. Slides were rinsed in 23 SSC (13 SSC is 150 mM NaCl plus 15 mM sodium
citrate [pH 7.0]) and then incubated for 1 h at 60°C in 200 ml of prehybridization
mixture, consisting of 50% deionized formamide, 43 SSC, 10% dextran sulfate,
13 Denhardt’s solution (0.02% Ficoll 400, 0.02% polyvinylpyrrolidone, 0.02%
BSA), 2 mM EDTA, and 500 mg of salmon testis DNA (Sigma) per ml. Labeled
probe (0.1 ng/ml) was added to the prehybridization mixture, and hybridization
was performed overnight at 56°C.
After hybridization, slides were washed twice in 43 SSC for 5 min at room
temperature, once in 23 SSC for 5 min at 45°C, once in 0.23 SSC containing
60% formamide for 5 min at 45°C, twice in 23 SSC for 5 min at room temper-
ature, twice in 0.23 SSC for 5 min at room temperature, and once in buffer I (100
mM maleic acid, 150 mM NaCl [pH 7.5]) for 5 min at room temperature. The
anti-DIG-alkaline phosphatase conjugate (Boehringer Mannheim) was diluted
according to the manufacturer’s recommendation in buffer II (1% blocking
reagent in buffer I; Boehringer Mannheim), and incubation was carried out for
1 h at room temperature. Slides were washed twice in buffer I for 5 min each and
then once in buffer III (100 mM Tris-HCl, 100 mM NaCl, 50 mM MgCl2 [pH
9.5]). Slides were next incubated with color substrate solution consisting of
4-nitroblue tetrazolium chloride (Boehringer Mannheim) and 5-bromo-4-chloro-
8658 WINKLER ET AL. J. VIROL.
 at U
N
IV
 O
F
 N
E
B
R
A
S
K
A
-LIN
C
O
LN
 on S
eptem
ber 19, 2007 
jvi.asm
.org
D
ow
nloaded from
 
3-indolylphosphate (X-phosphate; Boehringer Mannheim) in buffer III. The
color reaction was stopped with TE buffer (10 mM Tris-HCl, 1 mM EDTA [pH
8.0]). Slides were counterstained in methyl green and coverslipped as described
above.
Immunohistochemistry (IHC). Tissues sections, deparaffinized and rehydrated
in graded ethanol series as described above, were treated with 0.05% protease
(type XIV; Sigma) in Tris buffer (0.05 M Tris [pH 7.6]) for 7 min at room
temperature. Nonspecific binding was blocked by incubation with 5% normal
swine serum (Sigma) for 45 min at room temperature. The monoclonal antibod-
ies used for this study were IgG2a directed against BHV-1 gD (MM113), IgG2a
anti-bovine CD2 (IL-A42), IgG1 anti-bovine CD4 (MCA834; Serotec), IgG2a
anti-bovine CD8 (MCA837; Serotec), and IgG anti-bovine macrophage
(MCA920; Serotec). Each antibody was diluted to a final concentration of 1 to 5
mg/ml in PBS with 1% BSA, applied to the slides, and then incubated overnight
at 4°C. Primary antibodies were detected by using large-volume DAKO LSAB 2
kit alkaline phosphatase (Dako Corp., Carpinteria, Calif.) according to the man-
ufacturer’s directions. Finally, the slides were incubated with freshly prepared
substrate (Vector Red Alkaline Phosphatase Substrate Kit I; Vector Laborato-
ries) for 5 to 10 min, rinsed with distilled water, counterstained in methyl green
(Vector Laboratories), and coverslipped before microscopic examination. The
specificity of the assay was assessed by the lack of positive signal when the gD
monoclonal antibody was incubated with tissue from mock-infected calves. A
negative reaction using mouse nonimmune serum incubated with mock-infected
and BHV-1-infected tissues was also used as a control.
Nucleic acid extractions. DNA and RNA were extracted from bovine tissues
from mock-infected and BHV-1-infected calves as described previously (47).
Total RNA was extracted from previously purified CD41 and CD81 lymphocytes
by using RNAgents (Promega Co., Madison, Wis.) according to the manufac-
turer’s instructions. DNA extraction from purified CD41 and CD81 lymphocytes
was performed as described before (47).
DNase I treatment, RT, and PCR. DNase I treatment, reverse transcription
(RT), and PCR were done as described before (47), using primers specific for
BHV-1 genes. The IE gene tested was bICP0, and the primers are TTCTCTG
GGCTCGGGGCTGC (sense) and AGAGGTCGACAAACACCCGCGGT
(antisense). The E gene tested was ribonucleotide RR, and the primers are
GACCGCCTGCTCGCTGCTATCC (sense) and GCCTGTGTAGTTGGTGC
TGCGGC (antisense). The late (L) gene tested was gC, and the primers are
GAGCAAAGCCCCGCCGAAGGA (sense) and TACGAACAGCAGCACGG
GCGG (antisense). All oligonucleotides are listed 59 to 39.
Electron microscopy. Lymphoid tissue from mock-infected and BHV-1-in-
fected calves (7 dpi) were cut into 1-mm3 cubes and fixed in 2% buffered
glutaraldehyde. Samples were postfixed in 1% osmium tetroxide in phosphate
buffer and stained en bloc with uranyl acetate. After dehydration, samples were
embedded in Epon araldite, cut into thin sections, stained with lead citrate and
uranyl acetate, and then examined with a Philips 410 microscope.
Statistical analyses. Differences in CD41 and CD81 lymphocyte percentages
were analyzed by independent t test using a two-tailed P value and P , 0.05 as
the criterion for statistical significance.
FIG. 1. In situ detection of cell death in tissues from mock-infected and BHV-1-infected calves. Thin sections were prepared from various tissues. Free 39-OH
termini were detected by the addition of terminal deoxynucleotidyltransferase and revealed by the anti-DIG-alkaline phosphatase conjugate. Trachea (A to C),
pharyngeal tonsil (D to F), and turbinate mucosa (G to I) were tested. Original magnifications: samples from mock-infected calves (A, D, and G), 3100; samples from
BHV-1-infected calves at 7 dpi, 340 (E) and 3100 (B, H, and F); samples from infected calves at 7 dpi (C and I), 3250. Methyl green was used as counterstaining.
Dark purple color indicates the TUNEL1 cells.
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RESULTS
BHV-1 infection induces apoptosis in lymphoid tissues. To
determine if apoptosis occurred in lymphoid tissue after
BHV-1 infection, calves were infected for 7 days and apoptosis
was examined in lymph nodes. Previous studies established
that cultured lymphocytes undergo apoptosis when infected (9,
16–18), but it is not known if apoptosis occurs when calves are
infected. Pharyngeal tonsil contained many TUNEL-positive
(TUNEL1) cells at 7 dpi (Fig. 1E and F) relative to mock-
infected calves (Fig. 1D). TUNEL1 cells were localized in the
corticomedullary junction in germinal centers of secondary
lymphoid follicles and subcapsular regions (Fig. 1E and F; Fig.
2B and D). TUNEL1 cells were also detected in lymphoid
areas located within the tracheal submucosa, which corre-
FIG. 2. In situ detection of cell death in lymph nodes from mock-infected and BHV-1-infected calves. Thin sections were prepared as described for Fig. 1 from
cervical lymph nodes from a mock-infected (A) and a BHV-1-infected calf (B), retropharyngeal lymph nodes from a mock-infected (C) and a BHV-1 infected calf (D),
and inguinal lymph nodes from a mock-infected (E) and a BHV-1 infected calf (F). All samples are at a magnification of 3100. Methyl green was used to counterstain.
Dark purple color indicates the TUNEL1 cells.
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sponds to mucosa-associated lymphoid tissue (Fig. 1B and C),
and turbinate membrane (Fig. 1H and I).
To determine if lymph nodes near the site of infection con-
tained increased TUNEL1 cells, cervical and retropharyngeal
lymph nodes were examined at 7 dpi. Relative to mock-in-
fected calves, cervical and retropharyngeal lymph nodes con-
tained more TUNEL1 cells and staining was located in or near
the follicle (Fig. 2B and D). Inguinal lymph node from infected
calves also had TUNEL1 cells (Fig. 2F), but fewer than in
pharyngeal tonsil. As expected, few or no TUNEL1 cells were
detected in the corresponding tissues of mock-infected animals
(Fig. 1A, D, and G; Fig. 2A, C, and E). In summary, following
infection, higher levels of TUNEL1 cells were detected in
pharyngeal tonsil and other lymph nodes.
As expected, electron microscopy revealed that lymphocytes
from mock-infected calves had no marginally condensed chro-
matin (Fig. 3A and B). In contrast, lymphocytes in lymph
nodes of infected cattle contained condensed chromatin and
other morphological characteristics seen during apoptosis.
One apoptotic lymphocyte from a lymphoid follicle in pharyn-
FIG. 3. Electron microscopy of pharyngeal tonsil from mock-infected and BHV-1-infected calves. Mock-infected and BHV-1-infected calves were euthanized, and
pharyngeal tonsil tissue was collected, fixed in 2% buffered glutaraldehyde, and embedded in Epon araldite. Thin sections were stained with lead citrate and uranyl
acetate and then examined with a Philips 410 microscope. (A and B) Sections from the germinal center in pharyngeal tonsil prepared from a mock-infected calf
(magnification of 36,000 [A] and 14,000 [B]); (C to F) micrographs of a BHV-1-infected calf (7 dpi). In panels C and D, a phagocytic cell (39,000 and 320,000) is
in the process of engulfing the apoptotic lymphocyte; in panels E and F, the same apoptotic lymphocyte contains herpesvirus nucleocapsids (arrows) measuring 105
nm in diameter (340,000 and 390,000).
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geal tonsil of BHV-1-infected calves is shown in Fig. 3C to F.
This lymphocyte has condensed chromatin shaped like a horse-
shoe or half-moon (Fig. 3C to F). The cell adjacent to the
lymphocyte appears to be a dendritic cell or macrophage. The
close proximity of the lymphocyte to the large cell suggested
that it was phagocytosed. However, this was unlikely because
we found no evidence of two double membranes surrounding
the lymphocyte, which is indicative of phagocytosis. Herpesvi-
rus nucleocapsid structures measuring 105 nm in diameter
were detected inside the apoptotic nucleus (Fig. 3E and F). All
apoptotic lymphocytes had morphological changes consistent
to that shown in Fig. 3C, and many contained herpesvirus
nucleocapsids within apoptotic nuclei.
To test whether infection led to decreased levels of CD41
and CD81 T-lymphocyte populations in pharyngeal tonsil and
retropharyngeal lymph nodes, mononuclear cells were pre-
pared by density gradient centrifugation. Adherent cells were
separated from the other mononuclear cells by incubating on a
plastic culture dish for 2 h at 37°C in a humidified CO2 incu-
bator. T cells were not readily detected in the adherent pop-
ulation based on cell morphology and hematoxylin-eosin stain-
ing (57). At 7 dpi, threefold fewer CD41 T cells were detected
in the pharyngeal tonsil (n 5 2, P 5 0.013). CD81 T-cell
numbers were also decreased in the pharyngeal tonsil at 7 dpi
(n 5 2, P 5 0.022) (Fig. 4). The retropharyngeal lymph node
also had decreased levels of CD41 T cells (n 5 2, P 5 0.02)
and CD81 T cells (n 5 2, P 5 0.028) at 7 dpi. In summary,
these results demonstrated that lymph nodes located close to
the initial site of infection contained high levels of apoptotic
lymphocytes, herpesvirus nucleocapsids were detected in these
lymphocytes, and the numbers of T cells decreased.
Detection of gD in lymphoid tissue of infected calves. The
results in Fig. 1 to 3 suggested that BHV-1 could infect lym-
phocytes of calves, leading to a reduction in the number of T
cells in the tonsil and retropharyngeal lymph nodes. To test
this hypothesis, we examined the relevant tissues for viral gly-
coprotein (gD) by using a monoclonal antibody and IHC. gD
was consistently detected in lymphoid and nonlymphoid tissues
from two infected calves but not from two uninfected calves
(Fig. 5 and data not shown). In lymphoid tissues, gD was
detected in the germinal centers, the corticomedullary junction
of lymphoid follicles, the subcapsular region, and randomly
throughout individual lymphoid tissues (Fig. 5A and B). gD
was also detected in the submucosa of turbinate and trachea
(Fig. 5F and H). Consecutive sections of pharyngeal tonsil
revealed that some of the infected cells also expressed the
lymphocyte surface protein CD2 present in the germinal center
(Fig. 5A to D). We observed overlapping of gD and CD21 cells
in 13 individual cells from a single germinal center. The loca-
tion of these CD21 T lymphocytes suggested they are CD41 T
cells, which are normally present in germinal centers to acti-
vate B lymphocytes. In other lymph nodes (cervical, retropha-
ryngeal, and parotid), gD was also detected (data not shown).
A few gD-positive cells were present in the inguinal lymph
node (Fig. 5J). Although this study suggested that gD was
expressed in these tissues as a result of productive infection, it
was also possible that virus was delivered to lymph nodes via
the lymphatic system but infection did not occur.
Analysis of T lymphocytes in PBMC during acute infection.
Figures 1 to 5 demonstrated that virus infection of lymphocytes
occurred in lymphoid tissue near the site of infection. How-
ever, it was not clear whether circulating lymphocytes become
infected or undergo apoptosis as a consequence of infection.
Six-month-old calves that were seronegative for BHV-1 were
bled three times before BHV-1 infection, and the normal levels
of CD41 and CD81 T lymphocytes were compared to those in
infected calves. After BHV-1 infection, calves were bled at
regular intervals (5, 7, 9, 12, and 16 dpi) and the distribution of
CD41 and CD81 T lymphocytes was determined. It was not
necessary to incubate PBMC with plastic to remove adherent
cells and debris because T cells in PBMC were readily sepa-
rated from other cell populations during FACS (57). BHV-1
infection reduced the CD41 T-cell population in PBMC at
days 5 (n 5 4, P 5 0.014), 7 (n 5 4, P 5 0.002), 9 (n 5 3, P 5
0.009), and 12 (n 5 4, P 5 0.008) (Table 1). CD81 T-cell
populations also decreased slightly at days 7 (n 5 4, P 5 0.001)
and 9 (n 5 3, P 5 0.010).
Two-color immunofluorescence of PBMC to measure apo-
ptosis in CD41 and CD81 T lymphocytes was performed with
mouse anti-bovine CD4 and CD8 antibodies, FITC-labeled
secondary antibodies, and PI. The percentage of apoptotic
cells was determined by measuring the subgenomic DNA peak
in mock-infected and infected calves at different times postin-
fection. Figure 6 shows representative data from flow cytomet-
ric analysis stained with PI. Increased apoptosis was detected
in CD41 T lymphocytes from PBMC at days 5 (n 5 2, P 5
0.006), 7 (n 5 2, P 5 0.002), 9 (n 5 2, P 5 0.002), and 16 (n 5
2, P 5 0.022) after infection. At 7 dpi, numbers of CD41 T
cells undergoing apoptosis were 30-fold higher than in the
same animal prior to infection. In contrast, the number of
apoptotic CD81 T lymphocytes was not significantly different
from the number in BHV-1-infected calves (P . 0.05). In
FIG. 4. Analysis of T-lymphocyte populations in pharyngeal tonsil and ret-
ropharyngeal lymph nodes. CD41 and CD81 lymphocytes from mock-infected
and BHV-1-infected calves (7 dpi) were prepared from pharyngeal tonsil and
retropharyngeal lymph node as described in Materials and Methods. Mononu-
clear cells were incubated with monoclonal antibodies directed against bovine
CD41 and CD81 T cells. FITC- or PE-conjugated IgG that was directed against
the monoclonal antibody was used as a secondary antibody. FITC- or PE-positive
cells were identified by flow cytometry.
FIG. 5. gD and CD2 detection by IHC on tissue sections of mock-infected and BHV-1-infected calves. Tissue sections were incubated with gD or CD2 monoclonal
antibodies overnight at 4°C. After the slide was washed, the biotinylated secondary antibody was added. The alkaline phosphatase reaction was performed as described
in Materials and Methods. (A and B) Pharyngeal tonsil stained for BHV-1 gD in BHV-1-infected calves (7 dpi) (magnifications of 3100 and 3250, respectively); (C
and D) pharyngeal tonsil stained for the lymphocyte surface protein CD2 (magnification of 3100 and 3250, respectively) in consecutive sections from panels A and
B; (E to I) gD staining of tissue from the turbinate membrane (F), tracheal submucosa (H), and inguinal lymph nodes (J) of calves infected for 7 days and gD staining
of turbinate mucosa (E), tracheal mucosa (G), and inguinal lymph node (I) of an infected calf (all at a magnification of 3250). The results are representative of data
obtained from three different calves.
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summary, the results demonstrated that infection increased the
number of apoptotic CD41 T cells but not CD81 cells in
PBMC, which resulted in a transient decrease in T cells during
acute infection.
Detection of BHV-1 DNA in lymphocytes. PCR was per-
formed with gC-specific primers to determine if BHV-1 DNA
was present in pharyngeal tonsil, cervical, retropharyngeal, pa-
rotid, and inguinal lymph nodes and in PBMC. The expected
product of 229 bp was amplified in the tissue from an infected
calf at 7 dpi (Fig. 7A, lanes 11 to 15) but not in the tissue from
a mock-infected calf (lanes 5 to 10). No PCR product was
amplified from the nontemplate control (lane 2) or from un-
infected MDBK cells (lane 4). The two positive controls,
MDBK cells infected for 18 h with BHV-1 (lane 3) and tri-
geminal ganglia from a BHV-1-infected calf (lane 16), con-
tained the 229-bp PCR product.
As expected, no PCR product was amplified from the non-
template control (Fig. 7B, lane 2) or uninfected MDBK cells
(lane 3). The amplified product was also not detected in PBMC
(lanes 5 to 7) or T lymphocytes prepared from pharyngeal
tonsil (lanes 14 and 15) of a mock-infected calf. The amplified
229-bp product was detected when DNA was prepared from
PBMC and from sorted CD41 lymphocytes at 5 and 7 dpi
(lanes 8, 9, 11, and 12). CD41 lymphocytes from pharyngeal
tonsil at 7 dpi also contained the amplified product (lane 16).
BHV-1 DNA was not detected in CD81 lymphocytes at 5 and
7 dpi from PBMC and from pharyngeal tonsil (lanes 10, 13,
and 17).
To rule out the possibility that the PCR results was not due
to contaminating non-T cells, ISH was performed with sorted
CD41 and CD81 T lymphocytes from mock-infected and
BHV-1-infected calves. The DIG-labeled BHV-1 gC probe
(229 bp) used for these studies was detected with anti-DIG-
alkaline phosphatase conjugate. BHV-1 DNA was not de-
tected in mock-infected CD41 and CD81 lymphocytes pre-
pared from PBMC (Fig. 8A and B). CD41 T cells from both
BHV-1-infected calves showed positive hybridization signal at
7 dpi (Fig. 8C and E). Approximately 13% of the CD41 T
lymphocytes were BHV-1 positive at 7 dpi. BHV-1 DNA was
FIG. 6. Analysis of apoptosis in T-lymphocyte populations prepared from PBMC. CD41 and CD81 lymphocytes were prepared from PBMC of mock-infected and
infected calves as described in Materials and Methods. Ethanol-fixed lymphocytes were stained with Telford reagent. The PI fluorescence of individual cells with
hypodiploid DNA content was measured with a flow cytometer.
FIG. 7. Detection of BHV-1 DNA in lymphoid tissue and lymphocytes after
infection. (A) Pharyngeal tonsil, cervical, retropharyngeal, parotid, and inguinal
lymph nodes and trigeminal ganglia were collected from euthanized calves. DNA
extraction and PCR conditions were as described in Materials and Methods.
Lanes: 1 and 17, molecular weight marker (100-bp DNA ladder); 2, no-template
control; 3, MDBK cells infected with BHV-1 for 16 h; 4, mock infected MDBK
cells; 5 to 10, pharyngeal tonsil, cervical, retropharyngeal, parotid, and inguinal
lymph nodes and trigeminal ganglia, respectively, from a mock-infected calf; 11
to 16, pharyngeal tonsil, cervical, retropharyngeal, parotid, and inguinal lymph
nodes and trigeminal ganglia, respectively, from a BHV-1-infected calf (7 dpi).
The results are representative of four different infected calves. (B) PBMC were
prepared by equilibrium centrifugation. CD41 and CD81 lymphocytes were
prepared from PBMC and pharyngeal tonsil as described in Materials and
Methods. DNA extraction and PCR conditions were as described in Materials
and Methods. Lanes: 1 and 18, molecular weight marker (100-bp DNA ladder);
2, no-template control; 3, mock-infected MDBK cells; 4, MDBK cells infected
with BHV-1 for 16 h; 5, PBMC from a mock-infected calf; 6 and 7, CD41 (lane
6) and CD81 T cells (lane 7) prepared from peripheral blood of a mock-infected
calf; 8 to 10, PBMC, CD41, and CD81 cells (peripheral blood), respectively,
from a BHV-1-infected calf (5 dpi); 11 to 13, PBMC, CD41, and CD81 cells
(peripheral blood), respectively, from a BHV-1-infected calf (7 dpi); 14 and 15,
CD41 (lane 14) and CD81 (lane 15) cells (pharyngeal tonsil) from a mock-
infected calf; 16 and 17, CD41 (lane 16) and CD81 (lane 17) cells (pharyngeal
tonsil) from a BHV-1-infected calf (7 dpi). Two micrograms of DNA was used
for each PCR. The results are representative of four different infected calves.
TABLE 1. Flow cytometric analysis of CD41 and CD81
T lymphocytes from PBMCa
T lympho-
cytes
% of total T lymphocytes (no. of calves tested)
Mock 5 dpi 7 dpi 9 dpi 12 dpi 16 dpi
CD41 20.5 (3) 15.5 (4)b 14.5 (4)b 15.1 (3)b 15.8 (4)b 18.8 (2)
CD81 13.6 (3) 13.4 (4) 9.4 (4)b 9.1 (3)b 15.2 (4) 14.7 (2)
a Calves that were seronegative for BHV-1 were inoculated with 107 50%
tissue culture infective doses of BHV-1 per ml. At the indicated times, CD41 and
CD81 T lymphocytes were prepared from PBMC after density gradient centrif-
ugation on Histopaque 1083. Mononuclear cells were incubated with a mono-
clonal antibody directed against bovine CD4 or anti-bovine CD8. A secondary
antibody conjugated to FITC or PE was then incubated with the samples, and
flow cytometry was performed.
b Significant difference (P , 0.05, independent t test) compared with mock-
infected calves.
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FIG. 8. Detection of BHV-1 DNA by ISH in T lymphocytes prepared from PBMC. The gC probe and ISH conditions are described in Materials and Methods.
PBMC were prepared from mock-infected and BHV-1-infected calves by equilibrium centrifugation. CD41 and CD81 lymphocytes were sorted by FACS and applied
to slides by cytospin. Shown are CD41 (A) and CD81 (B) lymphocytes prepared from a mock-infected calf, CD41 (C) and CD81 (D) lymphocytes from a calf infected
for 7 days, and CD41 (E) and CD81 (F) lymphocytes from another calf infected for 7 days. Dark purple staining in the nucleus of CD41 T cells in panels C and E
was indicative of a positive ISH signal (denoted by arrows). Methyl green was used for counterstaining; magnification is 31,000.
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also detected in CD41 T lymphocytes at 5 and 9 dpi (data not
shown). At 7 dpi, less than 1% of the CD81 T lymphocytes
were positive, as judged by ISH (Fig. 8D and F). As judged by
hematoxylin-eosin staining by light microscopy, approximately
98% of the lymphocyte populations were small agranular cells
showing a relative high nuclear/cytoplasmic ratio. ISH-positive
lymphocytes were also detected in germinal centers of pharyn-
geal tonsil at 7 dpi (data not shown). In summary, these results
demonstrated that CD41 T cells contained BHV-1 DNA se-
quences.
Detection of viral gene expression in PBMC. To determine
if viral gene expression occurred in CD41 T cells, RT-PCR was
performed with primers that detect IE (bICP0), E (RR), or L
(gC) transcripts. Two-color immunofluorescence of PBMC was
performed to sort CD41 and CD81 T cells, and RNA was
prepared from the samples (47). bICP0 cDNA was amplified in
PBMC, and CD41 lymphocytes were prepared from PBMC at
7 dpi (Fig. 9A, lanes 11 and 13). RR transcripts were also
detected in PBMC and CD41 T cells (Fig. 9B, lanes 11 and
13). gC RNA was detected in PBMC and CD41 lymphocytes at
7 dpi in three of three PCRs from only one of three calves (Fig.
9C, lane 11 and 13). In contrast, RR and bICP0 were detected
in all calves tested. The same primers did not amplify cDNAs
from isolated CD81 lymphocytes at 7 dpi (Fig. 9A to C, lane
15). When reverse transcriptase was omitted from RT reac-
tions, amplified products were not detected in the positive
samples (Fig. 9A to C, lanes 10, 12, and 14). As expected, the
primers (bICP0, RR, and gC) did not amplify cDNA products
from mock-infected calves (Fig. 9A to C, lanes 5, 7, and 9). In
summary, expression of bICP0 and RR genes was consistently
detected in CD41 T cells but not CD81 T cells.
DISCUSSION
In this study, we demonstrated that infection of cattle with
BHV-1 leads to infection of CD41 T cells but not CD81 T
cells. gC RNA expression was not consistently detected in
PBMC or CD41 T cells, suggesting a block in the infection
cycle. Infection of CD41 T cells led to an increase in apoptosis.
It is also likely that the stress of infection resulted in higher
levels of corticosteroids, which can lead to lymphocyte apopto-
sis and immunosuppression (19a). Consequently, we hypothe-
sized that BHV-1 infection, directly and indirectly, induced
apoptosis of CD41 T cells, resulting in transient immunosup-
pression. This novel virus-host interaction is important because
it would increase the probability that secondary bacterial in-
fections occur.
Many viruses induce apoptosis when cultured cells are in-
fected (reviewed in references 41, 52, and 59). Previous studies
with cultured cells have shown that BHV-1 induces apoptosis
in activated T lymphocytes, mitogen-stimulated PBMC, B lym-
phocytes, monocytes, CD41 T lymphocytes (9, 13, 16–18), and
nonlymphoid cells (8). Prior to this study, it was not known
whether apoptosis occurred when cattle were infected.
TUNEL1 cells were detected in lymphoid tissues (pharyngeal
tonsil, cervical, retropharyngeal, and inguinal lymph nodes),
trachea, and turbinate membrane from infected calves at 7 dpi.
Viral DNA and proteins were also detected in the same sec-
tions that contained TUNEL1 cells, suggesting that virus in-
fection induced apoptosis.
Since the TUNEL assay can detect degradation of DNA
during necrotic cell death (29), electron microscopy was used
to confirm that apoptosis occurred. Apoptotic cells that have
the characteristic morphology and size of lymphocytes were
detected in the pharyngeal tonsil of infected calves at 7 dpi.
Apoptotic cells provide a potent stimulus for phagocytosis
through exposure of phospholipids (10), suggesting that this
occurs after BHV-1 infection. Viral nucleocapsids (105 nm),
which are typical for alphaherpesviruses (6), were frequently
detected inside the nuclei of apoptotic cells. Further studies
demonstrated that viral DNA (Fig. 7B and 8) and viral gene
expression (Fig. 9) occurred in CD41 T cells. Thus, reduction
of CD41 T cells was, in part, the result of virus infection and
apoptosis.
The presence of gD and TUNEL1 cells in germinal centers
and mucosa-associated lymphoid tissue suggested this was the
route used to infect T lymphocytes and disseminate through
the lymphatic system. CD21 T cells expressing BHV-1 antigens
within the germinal center of the pharyngeal tonsil may be
CD41 T helper cells (49). B cells present in germinal centers
require second signals, provided by CD41 T helper cells, for
their terminal differentiation to antibody-producing plasma
cells (reviewed in reference 46). An earlier study demonstrated
that BHV-1 infection can occur within germinal centers of
FIG. 9. Productive viral gene expression occurs in PBMC and lymphoid
tissue. RNA extraction, RT, and PCR were performed as described in Materials
and Methods. cDNAs were PCR amplified with bICP0 (A), RR (B), and gC (C)
primers. Lanes: 1 and 16, molecular weight marker (100-bp DNA ladder); 2 and
3, MDBK cells infected with BHV-1 without and with RT, respectively; 4 and 5,
PBMC from a mock-infected calf without and with RT, respectively; 6 and 7,
CD41 T cells prepared from a mock-infected calf without and with RT, respec-
tively; 8 and 9, CD81 T cells from a mock-infected calf without and with RT,
respectively; 10 and 11, PBMC from a BHV-1-infected calf without and with RT,
respectively; 12 and 13, CD41 T cells from a BHV-1-infected calf without and
with RT, respectively; 14 and 15, CD81 T cells from a BHV-1-infected calf
without and with RT, respectively.
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pharyngeal tonsil, but virus replication in leukocytes was not
detected (48). In this study, we were unable to demonstrate
that CD81 T cells (Fig. 7 to 9) were infected. It is tempting to
speculate that certain populations of CD41 T cells express a
protein that can serve as a receptor for virus infection. Other
viruses (e.g., canine distemper virus [24] and human herpesvi-
rus 6 [33, 35]), can also infect CD41 T cells and induce immu-
nosuppression, suggesting this is a common strategy to en-
hance virus spread in vivo.
A slight increase in apoptosis was also observed in CD81 T
cells (Fig. 6) and macrophages (data not shown) after infec-
tion. TUNEL1 macrophages could be the result of BHV-1
infection (16, 45) or related to phagocytosis of apoptotic bod-
ies. Since few CD81 T cells were positive for BHV-1 DNA, it
is possible that apoptosis observed in CD81 cells was related to
an indirect mechanism of virus infection, the bystander effect.
The bystander effect mediates apoptosis in CD81 T cells and
other uninfected cells of HIV-positive individuals (11, 25, 39).
With respect to human herpesvirus 6, entry and replication are
not required for induction of apoptosis in lymphocytes (21, 59).
Following infection of cattle, apoptosis of uninfected cells
could also be induced by CTL that have promiscuous cytotoxic
activity (31).
CD41 T cells, but not gamma/delta T cells or CD81 T cells,
were identified as the limiting cell type for antigen-induced
proliferation, thus playing a pivotal role in BHV-1 infection
(7). CD41 T cells are necessary to generate a CD81 CTL
response and viral clearance after infection with ectromelia
virus (28), vaccinia virus, lymphocytic choriomeningitis virus,
HSV (26), and Moloney sarcoma virus (3, 32). In ectromelia
virus infection, depletion of CD41 T lymphocytes reduces CTL
responses threefold and inhibits viral clearance. The presence
of CD81 T cells is required for viral clearance of influenza A
virus (4), ectromelia virus (28), and HSV (42) infection. CD4
depletion leads to higher titers of HSV-1 challenge virus at the
site of infection and increases viral load in trigeminal ganglia
(38). We suggest that BHV-1 infection and apoptosis of CD41
T cells contribute to immunosuppression and enhance estab-
lishment of latency.
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